Why the Janus Henderson (ASX:JHG) share price is plunging today

Janus Henderson Group (ASX:JHG) is heading the opposite way to Macquarie Group Ltd (ASX:MQG) today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Shares in international equities and fixed income fund manager Janus Henderson Group (ASX: JHG) (JANUS/IDR UNRESTR) are down nearly 5% today after the group reported its results for the quarter ending September 30, 2018. Below is a summary of the results with comparisons to the prior corresponding period. All figures in U.S. dollars.

  • Profit of $111.2 million, compared to $140.6 million in prior quarter
  • Revenue of $581.2 million, compared to $592.4 million in prior quarter
  • Total assets under management of US$378.1 billion, up 2% on prior quarter
  • Quarterly dividend of 36 cents per share
  • Adjusted earnings per share of 69 cents for quarter, down 7% on prior quarter
  • Diluted earnings per share of 55 cents, compared to 70 cents in prior quarter
  • Completed $50 million share buyback during the quarter
  • On track to achieve $125 million in cost savings by end of 2018

The group's revenue fall was primarily driven by lower performance fees that also flowed through to the lower profit and earnings per share. The other black marks were relatively weak (short term) investment performance over the quarter that may have contributed to the fund "flow challenges".

The market has responded to this disappointment by sending the shares close to a 52-week low today, with the stock down around 22% over the past year.

The group came about after the 2017 merger between Denver-based fixed income manager Janus and international equities specialist Henderson Group, which is headquartered in London.

Some of the thinking behind the merger was that the combined group could extract a lot of "synergies" or cost savings, and the fact that it is on track to pull out $125 million out of the business shows this.

Henderson Janus Group's share price has also been a victim of the terrible October for international equity markets as it charges revenues as a fixed percentage of fees under management.

Elsewhere in the asset management space international equities manger Macquarie Group Ltd (ASX: MQG) posted a solid result today, with its interim profit lifting 5%.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »